← Eichor
Study identifier: NCT02201589 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility of Endovascular Repair Of Ascending Aortic Pathologies

Condition: Aortic Dissection · Intramural Hematoma · Penetrating Ulcer  ·  Sponsor: Rodney A. White, MD

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to investigate the outcome of patients with pathologies of the ascending thoracic aorta (diseases in the great blood vessel or artery that leads away from the heart) including type A aortic dissection, retrograde type A aortic dissection, intramural hematoma, penetrating ulcer or pseudoaneurysm who are suitable for endovascular (within the vessel) repair with the Medtronic Valiant PS-IDE (Physician Sponsored-Investigational Device Exemption) Stent Graft. Type A aortic dissection is a condition where blood passes through the inner lining or between the layers of the blood vessel from a tear in the aortic wall (dissection) in the ascending aorta; a retrograde Type A aortic dissection is a condition where the dissection or tear in the ascending aorta starts from the descending aorta; an intramural hematoma is a collection of clotted blood within the aortic wall; a penetrating ulcer has a plaque or clot within the wall and a pseudoaneurysm is a false aneurysm . If left untreated in any of these conditions, the aorta can enlarge and rupture causing injury or death. The plan for these patients is to repair the ascending thoracic aorta using the Medtronic Valiant PS-IDE Stent Graft with the Captivia Delivery System. The Valiant Captivia has been evaluated worldwide and used extensively in patients with type B (descending) thoracic aortic dissection. Since the dissections in the ascending aortas mirror that of the descending aorta, it is expected that thi…

This description comes directly from the study's public registry record.

Talk to the study team

Rodney A White, M.D.  ·  310 222-2704  ·  rawhite@ucla.edu

Ali Khoynezhad, M. D., PhD  ·  310 423-3851  ·  ali.khoynezhad@cshs.org

Always discuss trial participation with your own doctor first.

Locations (3)

Long Beach Memorial Medical CenterLong Beach, California, United StatesRecruiting
Cedars Sinai Medical CenterLos Angeles, California, United StatesTerminated
LAC Harbor-UCLA Medical CenterTorrance, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02201589